CDKN2A and pulmonary fibrosis: Consistently, administration of DQ to mice with bleomycin-induced lung fibrosis significantly reduced transcriptional levels of P16 and several SASP factors in lung tissue and translated into improved measures of pulmonary and physical function in mice [8].